Cancer and Metastasis Reviews

Papers
(The TQCC of Cancer and Metastasis Reviews is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Editorial Expression of Concern: Targeting microRNAs as a promising anti-cancer therapeutic strategy against traffic-related air pollution-mediated lung cancer382
Clonal tracking in cancer and metastasis261
The functions and modifications of tRNA-derived small RNAs in cancer biology253
New insights for gynecological cancer therapies: from molecular mechanisms and clinical evidence to future directions166
Immunotherapy for leptomeningeal disease from solid tumors: current clinical outcomes and future opportunities148
Regulation of dormancy during tumor dissemination: the role of the ECM133
CAR T-cell therapy for B-cell lymphomas: outcomes and resistance mechanisms121
Immunotherapy for triple negative breast cancer: the end of the beginning or the beginning of the end?86
The impact of tumor microenvironment: unraveling the role of physical cues in breast cancer progression86
CAR T-cell therapy to treat multiple myeloma: current state and future directions75
The effect of GLP-1R agonists on the medical triad of obesity, diabetes, and cancer68
KISS1 metastasis suppressor in tumor dormancy: a potential therapeutic target for metastatic cancers?67
p73 isoforms meet evolution of metastasis62
Natural killer cells in neuroblastoma: immunological insights and therapeutic perspectives61
Cell-cell interactions mediating primary and metastatic breast cancer dormancy61
TRIM-endous functional network of tripartite motif 29 (TRIM29) in cancer progression and beyond53
Healthcare disparities, screening, and molecular testing in the changing landscape of non–small cell lung cancer in the United States: a review50
Biography—Mathieu Boissan, Pharm.D., Ph.D46
Preface46
Neuropeptide Y in cancer—biological functions and potential clinical implications45
Targeting microRNAs as a promising anti-cancer therapeutic strategy against traffic-related air pollution-mediated lung cancer45
The multifaceted mechanisms of malignant glioblastoma progression and clinical implications43
LGR5: An emerging therapeutic target for cancer metastasis and chemotherapy resistance43
How circulating tumor cluster biology contributes to the metastatic cascade: from invasion to dissemination and dormancy43
Biographies43
The role of cancer cell bioenergetics in dormancy and drug resistance42
Immunomodulatory role of oncogenic alterations in non-small cell lung cancer: a review of implications for immunotherapy38
Tumor necrosis factor superfamily signaling: life and death in cancer38
Helicobacter pylori–activated fibroblasts as a silent partner in gastric cancer development38
Clusterin: a marker and mediator of chemoresistance in colorectal cancer38
Short-chain fatty acids in cancer pathogenesis38
Clinical interventions to break the obesity and cancer link: a narrative review37
Tissue-engineered patient-derived osteosarcoma models dissecting tumour-bone interactions37
Vaping and tumor metastasis: current insights and progress36
The emerging roles of histone demethylases in cancers36
Carcinoma of unknown primary (CUP): an update for histopathologists35
Epigenetic reprogramming of T cells: unlocking new avenues for cancer immunotherapy34
Functional and clinical roles of stromal PDGF receptors in tumor biology33
Kenneth V. Honn, Ph.D. (1946–2023)33
Dormancy, stemness, and therapy resistance: interconnected players in cancer evolution32
OX40/OX40 ligand and its role in precision immune oncology31
Racial disparity in prostate cancer: an outlook in genetic and molecular landscape31
PRUNE1 and NME/NDPK family proteins influence energy metabolism and signaling in cancer metastases30
The role of mitochondria in tumor metastasis and advances in mitochondria-targeted cancer therapy30
CTGF (CCN2): a multifaceted mediator in breast cancer progression and therapeutic targeting29
UCP2 and pancreatic cancer: conscious uncoupling for therapeutic effect29
Ferroptosis: iron release mechanisms in the bioenergetic process28
Is cancer an intelligent species?28
Multifaceted role of the DNA replication protein MCM10 in maintaining genome stability and its implication in human diseases28
The strict regulation of HIF-1α by non-coding RNAs: new insight towards proliferation, metastasis, and therapeutic resistance strategies28
Current state-of-the-art on ganglioside-mediated immune modulation in the tumor microenvironment28
New progress of tuberculosis scar carcinoma28
HOXA9 transcription factor is a double-edged sword: from development to cancer progression28
Recent advances in synthetic strategies and SAR of thiazolidin-4-one containing molecules in cancer therapeutics28
0.53722906112671